[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,100,190
  • Shares Outstanding, K 56,408
  • Annual Sales, $ 738,260 K
  • Annual Income, $ 48,890 K
  • EBIT $ 65 M
  • EBITDA $ 160 M
  • 60-Month Beta 1.06
  • Price/Sales 10.79
  • Price/Cash Flow 41.33
  • Price/Book 3.77

Options Overview Details

View History
  • Implied Volatility 50.37% (+1.27%)
  • Historical Volatility 57.97%
  • IV Percentile 50%
  • IV Rank 42.98%
  • IV High 69.51% on 07/21/26
  • IV Low 35.94% on 08/14/25
  • Expected Move (DTE 20) 10.29 (7.29%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 13
  • Volume Avg (30-Day) 363
  • Put/Call OI Ratio 2.84
  • Today's Open Interest 10,465
  • Open Int (30-Day) 8,292
  • Expected Range 130.73 to 151.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.46
  • Number of Estimates 4
  • High Estimate $0.46
  • Low Estimate $0.45
  • Prior Year $0.46
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.00 +9.31%
on 07/21/26
154.00 -8.44%
on 07/28/26
+4.57 (+3.35%)
since 06/30/26
3-Month
100.99 +39.63%
on 05/14/26
154.00 -8.44%
on 07/28/26
+22.70 (+19.19%)
since 04/30/26
52-Week
100.99 +39.63%
on 05/14/26
175.77 -19.78%
on 01/06/26
+18.16 (+14.78%)
since 07/30/25

Most Recent Stories

More News
Why Repligen (RGEN) Stock Is Up Today

Why Repligen (RGEN) Stock Is Up Today

RGEN : 141.01 (-1.80%)
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026

RGEN : 141.01 (-1.80%)
Repligen: Q2 Earnings Snapshot

Repligen: Q2 Earnings Snapshot

RGEN : 141.01 (-1.80%)
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Second quarter revenue of $204 million, a year-over-year increase of 12% as reported and 13% organic GAAP operating income increased 1% year-over-year while adjusted operating income increased 55% ...

RGEN : 141.01 (-1.80%)
Repligen (RGEN) Q2 Earnings: What To Expect

Repligen (RGEN) Q2 Earnings: What To Expect

RGEN : 141.01 (-1.80%)
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of BioLife Solutions ...

BLFS : 31.28 (-1.14%)
RGEN : 141.01 (-1.80%)
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

TXG : 47.27 (-4.37%)
HIMS : 27.77 (+2.70%)
RGEN : 141.01 (-1.80%)
WST : 340.96 (+0.40%)
3 Cash-Producing Stocks That Concern Us

3 Cash-Producing Stocks That Concern Us

SHW : 340.85 (-1.16%)
EFX : 172.62 (-1.99%)
RGEN : 141.01 (-1.80%)
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

                  Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business...

RGEN : 141.01 (-1.80%)
BLFS : 31.28 (-1.14%)
Why Repligen (RGEN) Stock Is Trading Lower Today

Why Repligen (RGEN) Stock Is Trading Lower Today

RGEN : 141.01 (-1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 149.81
2nd Resistance Point 147.40
1st Resistance Point 144.21
Last Price 141.01
1st Support Level 138.60
2nd Support Level 136.20
3rd Support Level 133.00

See More

52-Week High 175.77
Fibonacci 61.8% 147.20
Last Price 141.01
Fibonacci 50% 138.38
Fibonacci 38.2% 129.56
52-Week Low 100.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.